PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Service d\'Immunologie, CHU Gabriel-Montpied, Clermont-Ferrand, France; Laboratoire d\'Immunologie, ECREIN, UMR1019 UNH, UFR Médecine de Clermont-Ferrand, Université Clermont Auvergne, Clermont-Ferrand, France.\', \'Service d\'Immunologie, CHU Gabriel-Montpied, Clermont-Ferrand, France.\', \'Service de Médecine Intensive et Réanimation, CHU Gabriel-Montpied, Clermont-Ferrand, France.\', \'Laboratoire de Bactériologie, CHU Gabriel-Montpied, Clermont-Ferrand, France.\', \'Service de Maladies Infectieuses et Tropicales, CHU Gabriel-Montpied, Clermont-Ferrand, France.\', \'Service d\'Immunologie, CHU Gabriel-Montpied, Clermont-Ferrand, France; Laboratoire d\'Immunologie, ECREIN, UMR1019 UNH, UFR Médecine de Clermont-Ferrand, Université Clermont Auvergne, Clermont-Ferrand, France. Electronic address: bevrard@chu-clermontferrand.fr.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S2352-3964(21)00415-110.1016/j.ebiom.2021.103622
?:hasPublicationType
?:journal
  • EBioMedicine
is ?:pmid of
?:pmid
?:pmid
  • 34678611
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.895
?:rankingScore_hIndex
  • 26
is ?:relation_isRelatedTo_publication of
?:title
  • Severe COVID-19 is characterized by the co-occurrence of moderate cytokine inflammation and severe monocyte dysregulation.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all